CD44highCD133+ CSC-like Subpopulation Contributes to BRAF Inhibitor Encorafenib Resistance in Malignant Melanoma

---

Çolakoğlu Bergel C., Eryılmaz I. E., Yöyen Ermiş D., Yağcıoğlu B., Çeçener G., Oral H. B., ...More

X. Multidisciplinary Cancer Research Congress, Eskişehir, Turkey, 8 - 11 May 2025, pp.73, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Eskişehir
• Country: Turkey
• Page Numbers: pp.73
• Bursa Uludag University Affiliated: Yes